Sort
51,593 grants matching “hepatitis”
Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer
$663,918Lopa Mishra · George Washington University · U01 · FY2020 · CA
GBV-C Natural History, Epidemiology, HIV Interaction
$663,858University Of Iowa · R01 · FY2004 · AI
Quantitative Dynamic Monitoring of MSCs and MSC-EVs in a Mouse Model of Intracerebral Hemorrhage
$663,854Shreyas Kuddannaya · University Of Miami School Of Medicine · R01 · FY2025 · EB
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury
$663,812Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2009 · AA
HUMAN REQUIREMENTS FOR THE NUTRIENT CHOLINE
$663,811University Of North Carolina Chapel Hill · R01 · FY2000 · DK
Novel Paxillin-FAK Inhibitors for the Treatment of Liver Fibrosis
$663,777Timothy A Marlowe · Faknostics, Llc · R42 · FY2025 · DK
Clinical Sciences Core (Core C)
$663,722David W Haas · Vanderbilt University Medical Center · P30 · FY2021 · AI
Ontogeny of drug transport
$663,667Bhagwat Prasad · Washington State University · R01 · FY2021 · HD
Adoptive MHC-E-Restricted T Cell Therapy for the Treatment of Chronic Hepatitis B Virus Infection
$663,585Benjamin J Burwitz · Oregon Health & Science University · R01 · FY2019 · AI
Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIV
$663,470Robert A Schnoll · University Of Pennsylvania · R01 · FY2019 · CA
ANGPTL3 DEFICIENCY AND ATHEROSCLEROSIS IN HUMANS
$663,467Nathan Oliver Stitziel · Washington University · R01 · FY2017 · HL
MECHANISMS OF CHRONIC HEPATITIS B INFECTION
$663,313Vaccine Research Institute Of San Diego · R01 · FY2003 · AI
Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE)
$663,202Peter D. Friedmann · Baystate Medical Center, Inc. · UG3 · FY2017 · DA
Structurally dissecting APOBEC3's for HIV-1 restriction and beyond
$663,123Celia A. Schiffer · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · AI
Novel therapies that target mitochondrial dysfunction for treatment of a1-antitrypsin deficiency liver disease
$663,075David A Rudnick · Washington University · R01 · FY2022 · DK
PRESERVATION OF BETA CELL FUNCTION IN PREDIABETES: IGT AND IFG
$663,044Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2019 · DK
PRESERVATION OF BETA CELL FUNCTION IN PREDIABETES: IGT AND IFG
$663,044Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2018 · DK
PRESERVATION OF BETA CELL FUNCTION IN PREDIABETES: IGT AND IFG
$663,044Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2021 · DK
Mechanisms of epithelial-mesenchymal crosstalk in intrahepatic biliary formation
$663,039Robert E Schwartz · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · DK
Multifidelity and multiscale modeling of the spleen function in sickle cell disease with in vitro, ex vivo and in vivo validations
$663,001George Karniadakis · Brown University · R01 · FY2021 · HL
CCR FACS Core Laboratory
$662,988Barbara Taylor · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Cognitive Function, Self-Management, and Health Outcomes among Liver Transplant Recipients: the LivCog Cohort
$662,784Marina Serper · University Of Pennsylvania · R01 · FY2024 · DK
Predicting post-transplant mortality and global functional health based on pre-transplant functional status in liver transplantation
$662,776Jennifer C. Lai · University Of California, San Francisco · R01 · FY2022 · AG
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging
$662,681Olga V Fedorova · National Institute On Aging · ZIA · FY2016 · AG
HBV Prevention for Homeless at Risk for HBV/HCV/HIV
$662,617Adeline M Nyamathi · University Of California Los Angeles · R01 · FY2009 · DA